Abbott names Nita Ahuja to Board of Directors; board expands to 13 members

ABBOTT LABORATORIES

Nita Ahuja, M.D. appointed to Abbott’s Board of Directors effective December 12, 2025.
Board size increased from 12 to 13 members via bylaw amendment on the same date.
Amended and restated by-laws filed as Exhibit 99.1; no additional details on Dr. Ahuja provided.

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

ABBOTT LABORATORIES: Increased board size from twelve to thirteen directors by amending Article III, Section 2 of the by-laws (effective 2025-12-12).

Change: bylaw amendment
Effective: 2025-12-12

Exact text from the filing

On December 12, 2025, Abbott’s Board of Directors amended the first sentence of Article III, Section 2 of Abbott’s by-laws to provide that Abbott’s Board of Directors shall consist of thirteen persons, effective as of December 12, 2025.

View on SEC.gov

Browse all governance changes →

ABBOTT LABORATORIES filing history →

Source: SEC EDGAR

accession 0001104659-25-120657

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.